Alpha Tides Research Library
Compound Research
Profiles
Complete research profiles for 21 compounds — covering mechanism of action, peer-reviewed study data, dosage research, pharmacokinetics, and storage protocols.
21
Research Pages
5
Categories
150
Citations
Tissue Repair & Recovery
Repair Peptides
Compound
BPC-157
Body Protective Compound — 15-amino acid pentadecapeptide studied for tendon repair, angiogenesis, and GI mucosal healing in preclinical models.
Compound
TB-500
Synthetic Thymosin Beta-4 fragment studied for actin regulation, angiogenesis promotion, and wound healing signaling in preclinical models.
Compound
Thymosin Beta-4 (Tβ4)
Endogenous 43-amino acid actin-sequestering peptide studied for cardiac regeneration, wound healing, and integrin-linked kinase activation.
Compound
GHK-Cu
Copper peptide tripeptide-glycyl-L-histidyl-L-lysine studied for collagen synthesis, skin regeneration, and wound healing signaling.
Growth Hormone Axis
GH Secretagogues & GHRH Analogs
Compound
Tesamorelin
Synthetic GHRH analog studied for GH stimulation, IGF-1 elevation, and visceral adipose tissue reduction in metabolic research models.
Compound
CJC-1295
Long-acting DAC-modified GHRH analog studied for sustained GH and IGF-1 elevation over extended dosing intervals.
Compound
Ipamorelin
Selective growth hormone secretagogue and ghrelin receptor agonist studied for GH pulse stimulation with minimal cortisol or prolactin side effects.
Compound
IGF-1 LR3
Long-acting IGF-1 analog with Arg3 substitution studied for muscle protein synthesis, cell proliferation, and metabolic signaling.
Compound
AOD-9604
C-terminal GH fragment (AOD 9604) studied for lipolysis stimulation without the IGF-1-mediated side effects of full-length GH.
Compound
Fragment 176-191
GH fragment spanning residues 176–191 studied for lipolytic activity in adipose tissue with proposed metabolic selectivity.
Compound
MOTS-c
Mitochondrial-derived peptide studied for AMPK activation, insulin sensitivity, exercise capacity enhancement, and metabolic regulation.
Cognitive & Neurological
Nootropic & CNS Peptides
Compound
Selank
Tuftsin-derived heptapeptide studied for anxiolytic activity, BDNF upregulation, and cognitive enhancement in preclinical models.
Compound
Semax
ACTH(4-7)-derived heptapeptide with melanocortin receptor activity studied for neuroprotection, BDNF elevation, and cerebrovascular research.
Compound
DSIP
Delta Sleep-Inducing Peptide — nonapeptide studied for sleep architecture modulation, stress response, and neuroendocrine regulation.
Compound
Epitalon (Epithalon)
Tetrapeptide studied for telomerase activation, circadian rhythm regulation, and aging-associated antioxidant signaling in longevity models.
Melanocortin System
Melanocortin Peptides
Compound
Melanotan II (MT-II)
Cyclic melanocortin agonist studied for tanning induction, erectile function, and appetite modulation via MC1R, MC3R, and MC4R activation.
Compound
PT-141 (Bremelanotide)
MC4R-selective melanocortin agonist with FDA approval for HSDD in women — studied for sexual arousal and erectile function pathways.
Metabolic Research
GLP-1 Analogs & Metabolic Compounds
Compound
Semaglutide
GLP-1 receptor agonist with Phase III clinical approval for type 2 diabetes and obesity. Studied for appetite suppression, insulin secretion, and cardiovascular risk reduction.
Compound
Tirzepatide
Dual GLP-1/GIP receptor agonist studied for enhanced weight reduction and glycemic control — demonstrated superior outcomes to GLP-1 mono-agonism in clinical trials.
Compound
Retatrutide
Triple GLP-1/GIP/Glucagon receptor agonist in Phase III trials. Studied for the most aggressive weight reduction outcomes observed in any pharmacological obesity trial.
Compound
Tesofensine
Triple serotonin/norepinephrine/dopamine reuptake inhibitor with Phase II clinical data showing 9–11% body weight reduction at studied doses over 24 weeks.
Research Library
Explore More Resources
Study summaries, lab protocols, reference charts, and safety documentation are available across the Alpha Tides Research Library.